Convatec

27-Oct-25

Corporate

Convatec announces Karim Bitar has passed away

Interim leadership arrangements remain in place and a further announcement will be made in due course

27-Oct-25

Corporate

Ostomy Care

Stigma, not condition, is the biggest barrier for 1 in 3 people living with c...

New report reveals that millions of people feel they need to hide their health conditions

01-Oct-25

Corporate

Convatec announces plans to invest more than $1 billion in R&D facilities – ...

Major expansions in the US and UK

22-Sep-25

Corporate

Advanced Wound Care

Convatec secures regulatory approval for ConvaMatrix™ in UK and Europe, suppo...

ConvaMatrix has significant potential for the management of hard to heal wounds such as venous leg ulcers and diabeti...

20-Aug-25

Corporate

Convatec commences share buyback programme

Non-discretionary share buyback programme to return up to $300 million of surplus capital to shareholders

29-Jul-25

Corporate

Financial Performance

Interim results for the six months ended 30 June 2025

Delivering broad-based revenue growth, margin expansion & double-digit EPS growth